Global Metabolomics Market 2019-2023
SKU ID : TNV-13808549 | Publishing Date : 23-Jan-2019 | No. of pages : 112
Detailed TOC of Global Metabolomics Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
• Market segmentation by application
• Comparison by application
• Biomarker and drug discovery - Market size and forecast 2018-2023
• Nutrigenomics - Market size and forecast 2018-2023
• Toxicology testing - Market size and forecast 2018-2023
• Market opportunity by application
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2018-2023
• Europe - Market size and forecast 2018-2023
• Asia - Market size and forecast 2018-2023
• ROW - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
• Increasing applications of metabolomics
• High potential for new techniques in metabolomics
• New developments in the field of metabolomics
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Agilent Technologies
• Bio-Rad Laboratories
• Bruker
• Human Metabolome Technologies
• METABOLON
PART 13: APPENDIX
• Research methodology
• List of abbreviations
Exhibit 01: Years in consideration
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Application - Market share 2018-2023 (%)
Exhibit 19: Comparison by application
Exhibit 20: Biomarker and drug discovery - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Biomarker and drug discovery - Year-over-year growth 2019-2023 (%)
Exhibit 22: Nutrigenomics - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Nutrigenomics - Year-over-year growth 2019-2023 (%)
Exhibit 24: Toxicology testing - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Toxicology testing - Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by application
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America - Year-over-year growth 2019-2023 (%)
Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 34: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Decision framework
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Agilent Technologies - Vendor overview
Exhibit 48: Agilent Technologies - Business segments
Exhibit 49: Agilent Technologies - Organizational developments
Exhibit 50: Agilent Technologies - Geographic focus
Exhibit 51: Agilent Technologies - Segment focus
Exhibit 52: Agilent Technologies - Key offerings
Exhibit 53: Bio-Rad Laboratories - Vendor overview
Exhibit 54: Bio-Rad Laboratories - Business segments
Exhibit 55: Bio-Rad Laboratories - Organizational developments
Exhibit 56: Bio-Rad Laboratories - Geographic focus
Exhibit 57: Bio-Rad Laboratories - Segment focus
Exhibit 58: Bio-Rad Laboratories - Key offerings
Exhibit 59: Bruker - Vendor overview
Exhibit 60: Bruker - Business segments
Exhibit 61: Bruker - Organizational developments
Exhibit 62: Bruker - Geographic focus
Exhibit 63: Bruker - Segment focus
Exhibit 64: Bruker - Key offerings
Exhibit 65: Human Metabolome Technologies - Vendor overview
Exhibit 66: Human Metabolome Technologies - Business segments
Exhibit 67: Human Metabolome Technologies - Organizational developments
Exhibit 68: Human Metabolome Technologies - Key offerings
Exhibit 69: METABOLON - Vendor overview
Exhibit 70: METABOLON - Business segments
Exhibit 71: METABOLON - Organizational developments
Exhibit 72: METABOLON - Key offerings
Exhibit 73: Validation techniques employed for market sizing
Exhibit 74: List of abbreviations
Keyplayers in Global Metabolomics Market 2019-2023
Agilent TechnologiesBio-Rad Laboratories
Bruker
Human Metabolome Technologies
METABOLON